Immunology
-
Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies
This article has 9 authors:Reviewed by ScreenIT
-
Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron
This article has 21 authors:Reviewed by ScreenIT
-
A Novel CRISPR-Engineered, Stem Cell-Derived Cellular Vaccine
This article has 16 authors:Reviewed by ScreenIT
-
Pipeline for retrieval of COVID-19 immune signatures
This article has 4 authors:Reviewed by ScreenIT
-
A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant
This article has 34 authors:Reviewed by ScreenIT
-
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine
This article has 28 authors:Reviewed by ScreenIT
-
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody
This article has 24 authors:Reviewed by ScreenIT
-
Deciphering the quality of SARS‐CoV‐2 specific T‐cell response associated with disease severity, immune memory and heterologous response
This article has 26 authors:Reviewed by ScreenIT
-
Evaluation of maternal-infant dyad inflammatory cytokines in pregnancies affected by maternal SARS-CoV-2 infection in early and late gestation
This article has 14 authors:Reviewed by ScreenIT
-
Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529
This article has 25 authors:Reviewed by ScreenIT